TickerFacts.

A business in context

BTAI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0001104659-26-104106 · Items 2.03,3.01

  2. 8-K · Current report

    Report date 2026-08-27 · 0001104659-26-102570 · Items 1.01,1.03

  3. 8-K · Current report

    Report date 2026-08-24 · 0001104659-26-100532 · Items 1.01,9.01

  4. 8-K · Current report

    Report date 2026-08-21 · 0001104659-26-099900 · Items 1.01,9.01

  5. 4 · Ownership change

    Report date 2026-08-12 · 0001104659-26-097388

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-095965

  7. 8-K · Current report

    Report date 2026-08-10 · 0001104659-26-093710 · Items 1.01,9.01

  8. 8-K · Current report

    Report date 2026-07-31 · 0001104659-26-089436 · Items 1.01,9.01

  9. 8-K · Current report

    Report date 2026-07-06 · 0001104659-26-080501 · Items 1.01,9.01

  10. 4 · Ownership change

    Report date 2026-06-15 · 0001104659-26-075302

  11. 4 · Ownership change

    Report date 2026-06-15 · 0001104659-26-075301

  12. 4 · Ownership change

    Report date 2026-06-15 · 0001104659-26-075300

  13. 4 · Ownership change

    Report date 2026-06-15 · 0001104659-26-075298

  14. 4 · Ownership change

    Report date 2026-05-04 · 0001104659-26-065841

  15. 4 · Ownership change

    Report date 2026-05-04 · 0001104659-26-065839

  16. 4 · Ownership change

    Report date 2026-05-04 · 0001104659-26-065838

  17. 8-K · Current report

    Report date 2026-05-15 · 0001104659-26-061773 · Items 2.02,9.01

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-061769

  19. 8-K · Current report

    Report date 2026-04-15 · 0001104659-26-044952 · Items 3.02,9.01

  20. 8-K · Current report

    Report date 2026-04-01 · 0001104659-26-038174 · Items 8.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-036214

  22. 8-K · Current report

    Report date 2026-03-27 · 0001104659-26-035661 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-03-10 · 0001104659-26-026409 · Items 1.01,9.01

  24. 8-K · Current report

    Report date 2026-02-12 · 0001104659-26-013840 · Items 8.01

  25. 8-K · Current report

    Report date 2026-02-04 · 0001104659-26-011595 · Items 5.02,9.01

  26. 8-K · Current report

    Report date 2026-01-20 · 0001104659-26-004787 · Items 8.01

  27. 8-K · Current report

    Report date 2026-01-12 · 0001104659-26-002697 · Items 8.01

  28. 8-K · Current report

    Report date 2025-12-12 · 0001104659-25-121180 · Items 5.07

  29. DEF 14A · Proxy statement

    Report date 2025-12-12 · 0001104659-25-110491

  30. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-109880

  31. 8-K · Current report

    Report date 2025-11-12 · 0001104659-25-109732 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-11-10 · 0001104659-25-108840 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-10-30 · 0001104659-25-104009 · Items 8.01

  34. 8-K · Current report

    Report date 2025-10-14 · 0001104659-25-098992 · Items 8.01

  35. 8-K · Current report

    Report date 2025-09-15 · 0001104659-25-089773 · Items 7.01,8.01

  36. 8-K · Current report

    Report date 2025-09-10 · 0001104659-25-088800 · Items 8.01

  37. 8-K · Current report

    Report date 2025-08-27 · 0001104659-25-083402 · Items 8.01

  38. 8-K · Current report

    Report date 2025-08-18 · 0001104659-25-079880 · Items 8.01,9.01

  39. 8-K · Current report

    Report date 2025-08-18 · 0001104659-25-079459 · Items 8.01

  40. 8-K · Current report

    Report date 2025-08-14 · 0001104659-25-079042 · Items 8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 0 transaction rows0AExercise / conversion: 24 transaction rows24MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

28 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-15
2026-06-17
Rodriguez JavierM · Exercise / conversion
Acquired
Common Stock35.0—
2026-06-15
2026-06-17
Rodriguez JavierM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
35.00.0
2026-06-15
2026-06-17
Steinhart Richard IM · Exercise / conversion
Acquired
Common Stock35.0—
2026-06-15
2026-06-17
Steinhart Richard IM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
35.00.0
2026-06-15
2026-06-17
Yocca FrankM · Exercise / conversion
Acquired
Common Stock35.0—
2026-06-15
2026-06-17
Yocca FrankM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
35.00.0
2026-06-15
2026-06-17
Mehta VimalM · Exercise / conversion
Acquired
Common Stock219.0—
2026-06-15
2026-06-17
Mehta VimalM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
219.00.0
2026-05-20
2026-05-22
Yocca Frank
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6845.01.09
2026-05-20
2026-05-22
Rodriguez Javier
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6560.01.08
2026-05-20
2026-05-22
Steinhart Richard I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6845.01.09
2026-05-20
2026-05-22
Mehta Vimal
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock19419.01.09
2026-05-04
2026-05-22
Yocca Frank
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17500.0—
2026-05-04
2026-05-22
Yocca Frank
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
17500.00.0
2026-05-04
2026-05-22
Rodriguez Javier
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17500.0—
2026-05-04
2026-05-22
Rodriguez Javier
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
17500.00.0
2026-05-04
2026-05-22
Steinhart Richard I
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17500.0—
2026-05-04
2026-05-22
Steinhart Richard I
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
17500.00.0
2026-05-04
2026-05-22
Mehta Vimal
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock49758.0—
2026-05-04
2026-05-22
Mehta Vimal
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
49758.00.0
2026-05-01
2026-05-07
Mehta VimalM · Exercise / conversion
Acquired
Common Stock18000.0—
2026-05-01
2026-05-07
Mehta VimalM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
18000.00.0
2026-05-01
2026-05-07
Steinhart Richard IM · Exercise / conversion
Acquired
Common Stock9000.0—
2026-05-01
2026-05-07
Steinhart Richard IM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
9000.00.0
2026-05-01
2026-05-07
Yocca FrankM · Exercise / conversion
Acquired
Common Stock9000.0—
2026-05-01
2026-05-07
Yocca FrankM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
9000.00.0
2026-05-01
2026-05-07
Rodriguez JavierM · Exercise / conversion
Acquired
Common Stock9000.0—
2026-05-01
2026-05-07
Rodriguez JavierM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
9000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001720893BioXcel Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$2.27M$2.41M
    2023-12-31$1.38M$1.51M
    2022-12-31$375.0K$427.8K

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗